UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2025
Commission File Number: 001-41661
Jin Medical International Ltd.
(Exact name of registrant as specified in its charter)
No. 33 Lingxiang Road, Wujin District
Changzhou City, Jiangsu Province
People’s Republic of China
(Address of Principal Executive Office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Jin Medical Launches Production at Plant No.
3 of Its Chuzhou Manufacturing Facility
Jin Medical International Ltd. (Nasdaq: ZJYL)
(“Jin Medical”, and together with all its subsidiaries, the “Company”), a Nasdaq-listed provider of rehabilitation
medical equipment reports that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. (“Zhongjin Anhui”),
has officially launched production at Plant No. 3 of Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, Anhui, China
(the “Facility”). The Company reports that the Facility is designed with an annual production capacity of approximately 200,000
units, laying a strong foundation for the Company’s steady expansion across regional frontiers.
On July 16, 2025 (China time), the Company published a
press release a copy of which is attached herein as Exhibit 99.1.
INCORPORATION BY REFERENCE
The above text of this report under the section
title “Jin Medical Launches Production at Plant No. 3 of Its Chuzhou Manufacturing Facility” shall be incorporated by reference
into the Company’s registration statement on Form F-3, initially filed with the SEC on June 25, 2025 as subsequently amended,
and be a part thereof from the date on which this Report is furnished to the SEC, to the extent not superseded by documents or reports
subsequently filed or furnished.
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release dated July 16, 2025 |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Jin Medical International Ltd. |
| |
|
|
| Date: July 16, 2025 |
By: |
/s/ Erqi Wang |
| |
|
Erqi Wang |
| |
|
Chief Executive Officer |
